fbpx

Allergan and Valeant unable to agree… even on a date

Valeant and investor

William Ackman have obtained a three-day trial to begin on October 6 in Delaware. The objective: to have the special meeting of Allergan shareholders moved up to mid-November from the December 18 date (see August 28, 2014 news clip).

 

At the meeting, shareholders will decide the fate of directors who oppose the hostile takeover bid by Valeant and Pershing Square.

 

Valeant and Ackman believe that Allergan chose the December 18 date to give it time to find an alternative deal. They argue that Allergan had no intention of calling the special meeting, an argument that Judge Andre Bouchard accepted in his decision.

 

Allergan continues to maintain that the December 18 date was chosen to give the court in California time to render its verdict in the lawsuit against Pershing Square, Ackman’s hedge fund, for insider trading.

 

Pershing Square secretly began accumulating Allergan shares in February 2014. It disclosed its nearly 10% stake on April 21. The next day, Valeant and Pershing Square announced their hostile takeover bid. Allergan’s shares were pushed higher and the value of Pershing Square’s stake in the company rose to $1 billion.

 

If Pershing Square loses its case, it will not be allowed to vote at Allergan’s special meeting, which is why it wants the meeting date bumped up. Stay tuned…

 

Source: http://www.reuters.com/assets/print?aid=USKBN0GR1RT20140827

Featured Posts

Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read more
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read more
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read more
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read more
Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read More
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read More
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read More
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read More
Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read more
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read more
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read more
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read more
Essilor Varilux physop extensee logo

Essilor Announces Latest Progressive Lens Innovation: Varilux® Physio® extensee Lens

Discover Varilux Physio extensee™, Essilor’s latest innovation in progressive lenses—sharp vision, better contrast, and pupil-adaptive comfort in all light.

Learn More
CooperVision

MiSight® Spectacle Lenses Powered by Diffusion Optics Technology™ Launches in Canada to Slow Myopia Progression

Breakthrough Approach First to Use Contrast Management, Supported by Extensive Clinical Studies; Proven Highly Effective in Children as Young as Six Years Old

Read more
Optik Voila May-June 2025 Mood Le PArc Marcellis

LE PARC – Timeless Lines, a Bold Perspective

From the Spring/Summer 2025 collection and “Dots” campaign, Marcelis is a sophisticated combination of acetate textures and timeless lines.

Read more
Safilo Group Victoria Beckham logos July 2025

Safilo, Victoria Beckham Announce Ten-Year Global Licensing Agreement for Eyewear Collections

Safilo and Victoria Beckham announce a global ten-year eyewear licensing agreement through 2035, with a new luxury collection debuting Spring-Summer 2026.

Read more
Fighting Blindness Canada research

AIPL1 Gene Therapy Restores vision in small clinical trial

Four children with Leber congenital amaurosis 4 (LCA4) have experienced meaningful improvements in their vision after receiving a gene therapy treatment.

Read more